TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Cigna ( (CI) ).
On October 22, 2025, Cigna‘s Board of Directors approved changes to its committee structure, effective January 1, 2026, to enhance corporate governance. The Compliance Committee’s responsibilities will be redistributed following the sale of certain business units in March 2025, leading to its dissolution. The Audit Committee will be renamed the Audit and Compliance Committee, and the Corporate Governance Committee will oversee ethics and clinical reporting. The Finance Committee will be renamed the Finance and Technology Committee, consolidating oversight of technology-related matters.
The most recent analyst rating on (CI) stock is a Buy with a $300.00 price target. To see the full list of analyst forecasts on Cigna stock, see the CI Stock Forecast page.
Spark’s Take on CI Stock
According to Spark, TipRanks’ AI Analyst, CI is a Outperform.
Cigna’s overall stock score reflects its solid financial performance and attractive valuation, which are offset by technical indicators suggesting a neutral to slightly bearish trend. The earnings call provided a positive outlook with strong revenue and earnings performance, though challenges remain in certain segments. The company’s strategic focus on innovation and client retention supports its growth trajectory.
To see Spark’s full report on CI stock, click here.
More about Cigna
Cigna is a prominent player in the health services industry, offering a range of products and services primarily focused on health insurance and related services. The company is committed to adapting to the evolving market landscape and maintaining strong corporate governance practices.
Average Trading Volume: 1,874,876
Technical Sentiment Signal: Sell
Current Market Cap: $72.03B
For detailed information about CI stock, go to TipRanks’ Stock Analysis page.